Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy
暂无分享,去创建一个
Yunyu Zhang | G. Jennings | E. Woodcock | S. Izumo | R. Bouwman | J. McMullen | K. Hewitt | P. Jay | T. Shioi | Martina Schinke-Braun | A. Buerger | J. Mollica | Li Zhang | F. Amirahmadi
[1] S. Cook,et al. Myostatin Regulates Cardiomyocyte Growth Through Modulation of Akt Signaling , 2006, Circulation research.
[2] Hyung-Suk Kim,et al. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. , 2006, The Journal of clinical investigation.
[3] K. Okkenhaug,et al. Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation , 2006, Nature.
[4] M. Emdin,et al. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. , 2006, Journal of the American College of Cardiology.
[5] William A Weiss,et al. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. , 2006, Cancer cell.
[6] D. Warburton,et al. Health benefits of physical activity: the evidence , 2006, Canadian Medical Association Journal.
[7] L. Leinwand,et al. Exercise Can Prevent and Reverse the Severity of Hypertrophic Cardiomyopathy , 2006, Circulation research.
[8] R. DePinho,et al. Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy , 2005, Molecular and Cellular Biology.
[9] G. Condorelli,et al. Akt Mediates the Cross-Talk Between &bgr;-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes , 2005, Circulation research.
[10] J. Rohn,et al. Gene Targeting Attention to Detail , 2004, Cell.
[11] L. Silengo,et al. PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects , 2004, Cell.
[12] R. Walsh. Molecular Mechanisms of Cardiac Hypertrophy and Failure , 2004 .
[13] Qing Nie,et al. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. , 2004, Physiological genomics.
[14] P. Kang,et al. The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110α) Pathway* , 2004, Journal of Biological Chemistry.
[15] Jian Xu,et al. Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy , 2004, Circulation research.
[16] A. Cohen-Solal,et al. Physical activity for primary and secondary prevention. Position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[17] P. Kang,et al. Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] I. Fraser,et al. Navigating the signalling network in mouse cardiac myocytes , 2002, Nature.
[19] J. Molkentin,et al. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. , 2002, Circulation research.
[20] P. Kang,et al. Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice , 2002, Molecular and Cellular Biology.
[21] A. Michelucci,et al. Increased Cardiac Sympathetic Activity and Insulin-Like Growth Factor-I Formation Are Associated With Physiological Hypertrophy in Athletes , 2001, Circulation research.
[22] P. Kang,et al. The conserved phosphoinositide 3‐kinase pathway determines heart size in mice , 2000, The EMBO journal.
[23] J. Christie,et al. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. , 1999, Journal of applied physiology.
[24] E. Woodcock,et al. Acute effects of cell isolation on InsP profiles in adult rat cardiomyocytes. , 1997, Journal of molecular and cellular cardiology.
[25] R. Fagard. Impact of different sports and training on cardiac structure and function. , 1997, Cardiology clinics.
[26] G. Jennings. MECHANISMS FOR REDUCTION OF CARDIOVASCULAR RISK BY REGULAR EXERCISE , 1995, Clinical and Experimental Pharmacology and Physiology.
[27] D. Levy,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.
[28] B. Ip. The role of physical activity in the prevention and treatment of noncommunicable diseases. , 1988 .
[29] B. Nadal-Ginard,et al. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. , 1988, Proceedings of the National Academy of Sciences of the United States of America.